Anton P. van de Woestijne

Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication

Anton P. van de Woestijne, Yolanda van der Graaf, Anho Liem et al. · Journal of the American College of Cardiology · 2013 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +9

Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study

Anho Liem, Anton P. van de Woestijne, Erik Bruijns et al. · International Journal of Cardiology · 2007 · 41 citations

Medicine, Cardiology, Internal Medicine +16

Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol

Anton P. van de Woestijne, Annemarie M.J. Wassink, Houshang Monajemi et al. · International Journal of Cardiology · 2012 · 37 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +12

ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients

Anho Liem, Anton P. van de Woestijne, H.W.O. Roeters van Lennep et al. · Current Medical Research and Opinion · 2007 · 33 citations

Medicine, Biostatistics, Cardiology +15

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease

Anton P. van de Woestijne, Yolanda van der Graaf, Paul I. W. de Bakker et al. · PLoS ONE · 2014 · 27 citations · Full text

Medicine, Genetics, Molecular Genetics +16